期刊文献+

阴离子交换蛋白2与原发性胆汁性胆管炎发病机制的关系

Role of anion exchanger 2 in the pathogenesis of primary biliary cholangitis
下载PDF
导出
摘要 原发性胆汁性胆管炎(PBC)的致病原因和发病机制仍不明确。目前主要认为胆管微环境变化和自身免疫反应是其发病的主要因素。阴离子交换蛋白2(AE2)是一种位于上皮细胞细胞膜上的HCO3-/Cl-交换蛋白,因发现其可以诱发和加重PBC的病程而被广大学者重视。从AE2以及相关调控机制着手,归纳总结了AE2在胆管微环境和自身免疫反应中所起到的作用,进一步对PBC的发病机制进行分析,以期通过探索AE2在PBC中的调控机制寻找到潜在的PBC治疗新方法以及诊断和预后判断指标。 The etiology and pathogenesis of primary biliary cholangitis(PBC)remain unclear at present,and it is believed that the change in bile duct microenvironment and autoimmune response are the main factors for the onset of this disease.Anion exchanger 2(AE2)is an HCO3-/Cl-exchange protein located on the membrane of epithelial cells and has been taken seriously by scholars since studies have shown that it can induce and aggravate PBC.This article summarizes the role of AE2 in bile duct microenvironment and autoimmune response from the aspects of AE2 and related regulatory mechanisms and further analyzes the pathogenesis of PBC,so as to find new therapies and diagnostic and prognostic indicators for PBC by exploring the regulatory mechanism of AE2 in PBC.
作者 鉏曦 邢练军 CHU Xi;XING Lianjun(Second Department of Spleen and Stomach, Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200000, China)
出处 《临床肝胆病杂志》 CAS 北大核心 2021年第3期718-720,共3页 Journal of Clinical Hepatology
基金 上海市进一步加快中医药事业发展三年行动计划(2018年—2020年)(ZY〔2018-2020〕-CCCX-2002-03) 上海市申康临床创新项目-新兴前沿技术联合攻关项目(SHDC12019118)。
关键词 原发性胆汁性胆管炎 反向转运物 病理过程 Primary Biliary Cholangitis Antiporters Pathologic Processes
  • 相关文献

参考文献5

二级参考文献83

  • 1Li-Min Li,Dong Wang,Ke Zen.MicroRNAs in Drug-induced Liver Injury[J].Journal of Clinical and Translational Hepatology,2014,2(3):162-169. 被引量:2
  • 2BEUERS U, GERSHWIN ME, GISH RG, et al. Changing no- menclature for PBC. From ' cirrhosis' to ' cholangitis' I- J ]. Gut, 2015, 64(11), 1671 -1672.
  • 3CHUANG N, GROSS RG, ODIN JA. Update on the epidemi- ology of primary biliary cirrhosis [ J ]. Expert Rev Gastroen- terol Hepatol, 2011, 5(5), 583-590.
  • 4JIANG XH, ZHONG RQ, FAN XY, et al. Characterization of M2 antibodies in asymptomatic Chinese population [ J ]. World J Gastroenterol, 2003, 9(91 : 2128 -2131 .
  • 5LIU H, LIU Y, WANG L, et al. Prevalence of primary biliary cir- rhosis in adults referring hospital for annual health check -up in Southern China[J]. BMC Gastroenterol, 2010, 10, 100.
  • 6MAYO MJ. Natural history of primary biliary cirrhosis[J]. Clin Uver Dis, 2008, 12(2) : 277 -288.
  • 7PRINCE M, CHETWYND A, NEWMAN W, et al. Survival and sympotom progression in geogapfically based cohort of patients with primay biliay cirrhosis, follow up for up to 28 years [ J ]. Gastroenterology, 2002, 123 (4) = 1044 - 1051.
  • 8IMAM MH, LINDOR KD. The natural histoy of primay biliay cirrhosis[J]. Semin Liver Dis, 2014, 34(3) ~ 329 -333.
  • 9PAR~:S A, CABALLERiA L, RODI~S J. Excellent long -term survival in patients with primary biliary cirrhosis and biochemi- cal response to ursodeoxycholic acid [ J ]. Gastroenterology, 2006, 130(3) : 715 -720.
  • 10CORPECHOT C, CHAZOUILLC:RES O, POUPON R, et al. Bio- chemical response to ursodeoxycholic acid and long -term prognosis in primary biliary cirrhosis~J~. Hepatology, 2008, 48 (3) : 871 -877.

共引文献253

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部